戻る Agenda
Session 2: Pharmacovigilance Updates & Collaboration Efforts From Around the Globe
Session Chair(s)
Shahinaz Badr, PHARMD
Founder & Managing Director
Vigilance Gate FZ,LLC, United Arab Emirates
Willemijn van der Spuij, MSC
Executive Director Europe | International - Patient Safety
Bristol Myers Squibb, Switzerland
This truly global session aims to provide insights into the latest developments in Pharmacovigilance. The session will take you on a journey around the world, starting with an exploration of PV requirements and experiences in Kazakhstan. We will then move on to the PV environment and collaborative efforts in Brazil. Next, we will focus on important PV developments in the Asia Pacific region. The session will highlight key aspects that impact the role of the QPPV. You will have the opportunity to engage directly with experts from the industry and regulatory agencies during the panel discussion.
Speaker(s)
Kazakhstan - Industry Experience of the Regulatory Framework and Interpretation to Inspection Experiences
Willemijn van der Spuij, MSC
Bristol Myers Squibb, Switzerland
Executive Director Europe | International - Patient Safety
Asia PAC Region – Increasing Role of NQPs Over Time
Representative Invited
Switzerland
Local QPPV Role in Egypt
Maha Mohamed Ahmed
Egyptian Drug Authority (EDA), Egypt
Acting Director of the general department of pharmacovigilance
LatAmScience LLC
United States
Diana Gonzalez, MD, MBA
Roche, Colombia
Colombia PSL & PV Policy Lead Latam